Status:
RECRUITING
Glycemic Metrics and Patterns in People With and Without Prediabetes
Lead Sponsor:
Abbott Diabetes Care
Conditions:
Pre Diabetes
Eligibility:
All Genders
18+ years
Brief Summary
The FreeStyle Libre 3 Continuous Glucose Monitoring (FSL3) System is used to characterize the glycemic profiles of people with and without a prediabetes diagnosis.
Detailed Description
This is a non-pivotal, non-randomized, multi-center, prospective, non-significant risk to evaluate the glycemic profiles of people with and without a prediabetes diagnosis using continuous glucose mon...
Eligibility Criteria
Inclusion
- Subject must be at least 18 years of age.
- Subject must be willing and able to provide written signed and dated informed consent.
Exclusion
- Subject has a diagnosis of type 1 diabetes, type 2 diabetes, or gestational diabetes.
- Subject is known to be currently practicing a low-carbohydrate or ketogenic diet at the time of enrollment.
- Subject is known to be pregnant at the time of enrollment.
- Subject has known allergy to medical grade adhesive, isopropyl alcohol and/or ethyl alcohol used to disinfect skin.
- Subject is currently on any form of treatment indicated for the treatment of diabetes.
- Subject is currently on any form of medication indicated for weight loss.
Key Trial Info
Start Date :
February 28 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT06921902
Start Date
February 28 2025
End Date
July 1 2026
Last Update
April 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Diabetes and Obesity Care
Bend, Oregon, United States, 97702